77 related articles for article (PubMed ID: 23500665)
41. Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations.
Chen J; Zhang C; Liu Q; Shao X; Feng C; Shen Y; Zhang Q; Jiang X
J Drug Target; 2012 Feb; 20(2):174-84. PubMed ID: 21992548
[TBL] [Abstract][Full Text] [Related]
42. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route.
Patel S; Chavhan S; Soni H; Babbar AK; Mathur R; Mishra AK; Sawant K
J Drug Target; 2011 Jul; 19(6):468-74. PubMed ID: 20958095
[TBL] [Abstract][Full Text] [Related]
43. Comparison of hypolipidemic activity of synthetic gallic acid-linoleic acid ester with mixture of gallic acid and linoleic acid, gallic acid, and linoleic acid on high-fat diet induced obesity in C57BL/6 Cr Slc mice.
Jang A; Srinivasan P; Lee NY; Song HP; Lee JW; Lee M; Jo C
Chem Biol Interact; 2008 Jul; 174(2):109-17. PubMed ID: 18571153
[TBL] [Abstract][Full Text] [Related]
44. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.
Gu G; Xia H; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Chen H; Gao X; Chen J
Biomaterials; 2013 Jan; 34(1):196-208. PubMed ID: 23069707
[TBL] [Abstract][Full Text] [Related]
45. Antiobesity effects of Chinese black tea (Pu-erh tea) extract and gallic acid.
Oi Y; Hou IC; Fujita H; Yazawa K
Phytother Res; 2012 Apr; 26(4):475-81. PubMed ID: 22508359
[TBL] [Abstract][Full Text] [Related]
46. Development and optimization of solid lipid nanoparticles of amikacin by central composite design.
Varshosaz J; Ghaffari S; Khoshayand MR; Atyabi F; Azarmi S; Kobarfard F
J Liposome Res; 2010 Jun; 20(2):97-104. PubMed ID: 19621981
[TBL] [Abstract][Full Text] [Related]
47. The GABAergic system contributes to the anxiolytic-like effect of essential oil from Cymbopogon citratus (lemongrass).
Costa CA; Kohn DO; de Lima VM; Gargano AC; Flório JC; Costa M
J Ethnopharmacol; 2011 Sep; 137(1):828-36. PubMed ID: 21767622
[TBL] [Abstract][Full Text] [Related]
48. Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting.
Bansal A; Kapoor DN; Kapil R; Chhabra N; Dhawan S
Acta Pharm; 2011 Jun; 61(2):141-56. PubMed ID: 21684843
[TBL] [Abstract][Full Text] [Related]
49. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
50. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Ray L; Kumar P; Gupta KC
Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
[TBL] [Abstract][Full Text] [Related]
51. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A
J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511
[TBL] [Abstract][Full Text] [Related]
52. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
Wohlfart S; Khalansky AS; Gelperina S; Begley D; Kreuter J
J Control Release; 2011 Aug; 154(1):103-7. PubMed ID: 21616104
[TBL] [Abstract][Full Text] [Related]
53. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
[TBL] [Abstract][Full Text] [Related]
54. In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery.
Xu Z; Gu W; Huang J; Sui H; Zhou Z; Yang Y; Yan Z; Li Y
Int J Pharm; 2005 Jan; 288(2):361-8. PubMed ID: 15620876
[TBL] [Abstract][Full Text] [Related]
55. Preparation and evaluation of paclitaxel-loaded nanoparticle incorporated with galactose-carrying polymer for hepatocyte targeted delivery.
Wang Y; Jiang G; Qiu T; Ding F
Drug Dev Ind Pharm; 2012 Sep; 38(9):1039-46. PubMed ID: 22124381
[TBL] [Abstract][Full Text] [Related]
56. Stability of a novel glycosylated peanut protein isolate delivery system loaded with gallic acid.
Zhang C; Li C; Zhu Y; Cui H; Lin L
Food Chem; 2024 Mar; 437(Pt 1):137790. PubMed ID: 37866342
[TBL] [Abstract][Full Text] [Related]
57. Antianxiety drugs and central nervous system symptoms in an ambulatory elderly population.
Hale WE; Stewart RB; Marks RG
Drug Intell Clin Pharm; 1985 Jan; 19(1):37-40. PubMed ID: 2857121
[TBL] [Abstract][Full Text] [Related]
58. Nutrient combinations exhibit universal antianxiety, antioxidant, neuro-protecting, and memory-improving activities.
Zhao B; Jia X; Feng H; Tang C; Huang Y; Zhao Z; Hao J; Li H; Du J; Liu Y; Bao X; Zhong Z; Zhang Y; Zhong Q
Front Nutr; 2022; 9():996692. PubMed ID: 36687677
[TBL] [Abstract][Full Text] [Related]
59. Pointers in antianxiety pharmacotherapy.
Ketai RM
West J Med; 1976 Sep; 125(3):233. PubMed ID: 18747796
[No Abstract] [Full Text] [Related]
60. Neurobiological effects of gallic acid: current perspectives.
Bhuia MS; Rahaman MM; Islam T; Bappi MH; Sikder MI; Hossain KN; Akter F; Al Shamsh Prottay A; Rokonuzzman M; Gürer ES; Calina D; Islam MT; Sharifi-Rad J
Chin Med; 2023 Mar; 18(1):27. PubMed ID: 36918923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
